๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for PDAC

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) NCT07217717Phase 319 sites๐Ÿ“ Cerritos๐Ÿ“ Duarte๐Ÿ“ Irvine SOFIE ยท Tests: [18F]FAPI-74 PET/CT A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma NCT06261359Phase 21 site๐Ÿ“ Beijing Qilu Pharmaceutical Co., Ltd. ยท Tests: CEND-1, Gemcitabine, Nab paclitaxel Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites๐Ÿ“ Copenhagen๐Ÿ“ Berlin๐Ÿ“ Dresden Anocca AB ยท Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting โ€ฆ Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site๐Ÿ“ Luxembourg Luxembourg Institute of Health ยท Tests: Personalized Functional Profiling A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) NCT07262957Phase 41 site๐Ÿ“ Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: HOP bundle KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Darlifarnib, Cabozantinib, Adagrasib AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Atlanta Amgen ยท Tests: AMG 410, Pembrolizumab, Panitumumab Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis NCT07030283Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Paclitaxel, NALIRIFOX A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer NCT07409272Phase 379 sites๐Ÿ“ Tucson๐Ÿ“ Fort Smith๐Ÿ“ Fullerton Astellas Pharma Global Development, Inc. ยท Tests: Setidegrasib, Oxaliplatin, Leucovorin, Irinotecan, fluorouracil A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Bristol-Myers Squibb ยท Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig Surgery for Locally Unresectable Pancreatic Cancer NCT07241663n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova ยท Tests: Questionnaire Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy NCT06747845Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine ยท Tests: Niraparib, FOLFIRI, Ipilimumab Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) NCT04926467Phase 21 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Anakinra Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma NCT07805954Phase 35 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville Revolution Medicines, Inc. ยท Tests: daraxonrasib, gemcitabine, nab-paclitaxel, zoldonrasib Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB) NCT06666803NA2 sites๐Ÿ“ Strasbourg๐Ÿ“ Strasbourg IHU Strasbourg ยท Tests: FNB sampling, blood sampling Advanced Therapies for Liver Metastases NCT04622423n/a1 site๐Ÿ“ Milan IRCCS San Raffaele A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT06790602Phase 21 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Cemiplimab Plus Gemcitabine Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals NCT06122896EARLY Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Screening Blood Tests, Endoscopic Ultrasound, Magnetic Resonance Imaging, Magnetic Resonance Cholangiopancreatography A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer NCT07644559Phase 238 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Verastem, Inc. ยท Tests: VS-7375, cetuximab (or panitumumab if ฮฑ-gal IgE+ or cetuximab reaction) Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer NCT06515587NA1 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: Lewis genotype detection reagent A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors NCT06914128Phase 1, Phase 263 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Los Angeles Bayer ยท Tests: BAY 3713372 A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer NCT07049055Phase 1, Phase 24 sites๐Ÿ“ El Segundo๐Ÿ“ Summit๐Ÿ“ New York Engeneic Pty Limited ยท Tests: E-EDV-D682, EDV-GC, Gemcitabine, Nab paclitaxel. M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors NCT07166601Phase 15 sites๐Ÿ“ New Haven๐Ÿ“ New York๐Ÿ“ San Antonio EMD Serono Research & Development Institute, Inc. ยท Tests: M0324, M0324, Pembrolizumab, mFOLFIRINOX Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors NCT06040541Phase 117 sites๐Ÿ“ Sacramento๐Ÿ“ New Haven๐Ÿ“ Sarasota Revolution Medicines, Inc. ยท Tests: RMC-9805, RMC-6236 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites๐Ÿ“ Orange๐Ÿ“ Santa Monica๐Ÿ“ Tampa Revolution Medicines, Inc. ยท Tests: RMC-6236 To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC NCT07591571NA1 site๐Ÿ“ Loma Linda Loma Linda University ยท Tests: PAL-CHW-PDAC, Usual Care with Attention Control Breath Research Narrow Validation for Gastrointestinal Cancer Detection NCT07714538n/a6 sites๐Ÿ“ Maidstone๐Ÿ“ Liverpool๐Ÿ“ Glasgow Imperial College London
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy